US Patent Issued to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services on Dec. 2 for "Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-responsive disease or disorder" (German, American Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,270, issued on Dec. 2, was assigned to THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-responsive disease or disorder" was invented by Giovanna Tosato (Bethesda, Md.), Michael J. DiPrima (Silver Spring, Md.), Harald Schwalbe (Frankfurt, Germany), Alix Troster (Frankfurt, Germany), Denis Kudlinzki (Heidelberg, Germany) and Nathalie Jores (Frankfurt, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ephrin type receptor tyrosine kinase inhibitors, also known as Eph tyrosine kinase receptor inhibito...